Gene · 6362
Papers4,584
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 4,584
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Erdheim-Chester disease presenting as large vessel vasculitis. | Rheumatol Adv Pract | 2023 | 37675203 | PubTator, text mining | PubMed |
| Integration of single-cell RNA sequencing and bulk RNA transcriptome sequencing reveals a heterogeneous immune landscape and pivotal cell subpopulations associated with colorectal cancer prognosis. | Front Immunol | 2023 | 37675100 | PubTator, text mining | PubMed |
| A programmed cell death-related model based on machine learning for predicting prognosis and immunotherapy responses in patients with lung adenocarcinoma. | Front Immunol | 2023 | 37671155 | PubTator, text mining | PubMed |
| The role of non-coding RNAs in extracellular vesicles in breast cancer and their diagnostic implications. | Oncogene | 2023 | 37670020 | PubTator, text mining | PubMed |
| The mycosis fungoides cutaneous microenvironment shapes dysfunctional cell trafficking, antitumor immunity, matrix interactions, and angiogenesis. | JCI Insight | 2023 | 37669110 | PubTator, text mining | PubMed |
| Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis-an exploratory study. | Arthritis Res Ther | 2023 | 37667402 | PubTator, text mining | PubMed |
| Comprehensive analysis of ACKR family members in breast cancer using prognostic values. | Oncol Lett | 2023 | 37664667 | PubTator, text mining | PubMed |
| Transcriptomic and proteomic assessment of tocilizumab response in a randomized controlled trial of patients hospitalized with COVID-19. | iScience | 2023 | 37664617 | PubTator, text mining | PubMed |
| Mechanisms of tumor-associated macrophages affecting the progression of hepatocellular carcinoma. | Front Pharmacol | 2023 | 37663266 | PubTator, text mining | PubMed |
| Integrated transcriptomics, proteomics and metabolomics-based analysis uncover TAM2-associated glycolysis and pyruvate metabolic remodeling in pancreatic cancer. | Front Immunol | 2023 | 37662928 | PubTator, text mining | PubMed |
| Delineating intra-tumoral heterogeneity and tumor evolution in breast cancer using precision-based approaches. | Front Genet | 2023 | 37662839 | PubTator, text mining | PubMed |
| Retracted: CCL18 Knockdown Suppresses Cell Growth and Migration in Thyroid Cancer. | J Healthc Eng | 2023 | 37662680 | PubTator, text mining | PubMed |
| Vernal Keratoconjunctivitis: A Systematic Review. | Clin Rev Allergy Immunol | 2023 | 37658939 | PubTator, text mining | PubMed |
| Tumor-associated macrophages confer colorectal cancer 5-fluorouracil resistance by promoting MRP1 membrane translocation via an intercellular CXCL17/CXCL22-CCR4-ATF6-GRP78 axis. | Cell Death Dis | 2023 | 37658050 | PubTator, text mining | PubMed |
| DIA-based analysis of the menstrual blood proteome identifies association between CXCL5 and IL1RN and endometriosis. | J Proteomics | 2023 | 37657716 | PubTator, text mining | PubMed |
| Antibody-mediated neutralization of galectin-3 as a strategy for the treatment of systemic sclerosis. | Nat Commun | 2023 | 37652913 | PubTator, text mining | PubMed |
| Correction: Adipose tissue specific CCL18 associates with cardiometabolic diseases in non-obese individuals implicating CD4+ T cells. | Cardiovasc Diabetol | 2023 | 37649001 | PubTator, text mining | PubMed |
| MUC16 stimulates neutrophils to an inflammatory and immunosuppressive phenotype in ovarian cancer. | J Ovarian Res | 2023 | 37644468 | PubTator, text mining | PubMed |
| Dissecting the tumor ecosystem of liver cancers in the single-cell era. | Hepatol Commun | 2023 | 37639704 | PubTator, text mining | PubMed |
| Deciphering the Cell-Specific Effect of Osteoblast-Macrophage Crosstalk in Periodontitis. | Tissue Eng Part A | 2023 | 37639358 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6362/papers?page=25